Article

What is the risk factor for metachronous colorectal carcinoma?

Diseases of the Colon & Rectum (impact factor: 3.13). 04/1997; 40(8):935-938. DOI:10.1007/BF02051201 pp.935-938

ABSTRACT PURPOSE: The purpose of this study was to determine the risk factors for developing metachronous colorectal carcinoma and to determine an adequate postoperative colonoscopic surveillance. METHODS: Two hundred eighty-four patients, examined by routine colonoscopy after resection for colorectal carcinoma, were reviewed. Clinical and pathologic factors were assessed by multiple logistic regression analysis. RESULTS: One hundred eighty-three patients with synchronous adenoma or carcinoma at the initial operation had a significantly higher incidence of both metachronous adenoma and carcinoma than the 101 patients without a synchronous lesion. Other clinical factors including age, gender, tumor stage, tumor site, and tumor grade were not significant for an increased incidence of metachronous carcinoma. The presence of synchronous lesions proved to be the only risk factor (relative risk, 3.293;P=0.0155) for developing metachronous carcinoma. Metachronous carcinoma was detected in 30 patients (10.6 percent) and completely removed from all patients. Mucosal carcinoma was found in 25 patients (8.8 percent) and invasive carcinoma in 5 patients (1.8 percent). All five invasive carcinomas were detected in asymptomatic patients having synchronous lesion. Four patients required a second operation for metachronous carcinoma more than 13 months following the first. CONCLUSION: The risk factor for developing metachronous carcinoma is the presence of synchronous adenoma or carcinoma at the initial operation. To detect metachronous carcinoma at a curable stage, annual colonoscopic surveillance should be performed for highrisk patients.

0 0
 · 
0 Bookmarks
 · 
18 Views

Keywords

25 patients
 
30 patients
 
5 patients
 
adequate postoperative colonoscopic surveillance
 
annual colonoscopic surveillance
 
asymptomatic patients
 
clinical factors
 
colorectal carcinoma
 
curable stage
 
five invasive carcinomas
 
highrisk patients
 
hundred eighty-three patients
 
invasive carcinoma
 
metachronous carcinoma
 
metachronous colorectal carcinoma
 
Mucosal carcinoma
 
multiple logistic regression analysis
 
routine colonoscopy
 
synchronous lesions
 
tumor stage
 

Toshiyuki Yamazaki